Public health officials warn against drawing broad conclusions from a 12-person observational cohort regarding the financial efficacy of workplace misconduct.
BOSTON — Preliminary findings from a 12-person cohort have associated ousted Cambridge scientist David Sabatini with $6 million in damages, though public health experts caution that the results are highly localized and may not be reproducible in a broader population of disgraced researchers.
The data, gathered during a multi-week observational trial in a Massachusetts courtroom, indicated a strong correlation between Sabatini’s career implosion following allegations of inappropriate sexual conduct by a much younger colleague and the sudden appearance of a multimillion-dollar legal windfall. However, researchers familiar with the methodology stressed that the sample size of one plaintiff remains statistically insufficient to establish a reliable baseline.
While the $6 million endpoint appears robust within this isolated trial, we cannot advise ousted biologists to immediately adjust their protocols to rely on defamation payouts.
A review of the literature published in a recent JAMA paper noted that proving a direct, causal link between inappropriate lab conduct and lucrative financial damages requires significantly more rigorous testing. Variables such as the age of the colleague, the specific nature of the ousted scientist's defense, and the placebo effect of high-priced legal representation make it difficult to isolate the exact mechanism of action behind the $6 million award.
The National Institutes of Health currently maintains that more research is needed before the Sabatini protocol can be safely generalized. Until a double-blind, peer-reviewed trial of ousted scientists is completed, the clinical guidance remains to treat the $6 million as an isolated, albeit highly elevated, anomaly.